This inventor holds 2 USPTO granted patents. Top assignees: Advanced Technologies and Regenerative Medicine, LLC, Lifesensors, Inc.. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011-2014
Title: Mabel Alarnino Cejas: Innovator in Protease Substrates and Collagen-Related Peptides
Introduction
Mabel Alarnino Cejas is a notable inventor based in Oreland, Pennsylvania. She has made significant contributions to the field of biochemistry, particularly in the development of synthetic protease substrates and collagen-related peptides. With two patents to her name, her work has implications for various applications in medical and scientific research.
Latest Patents
Cejas's latest patents include "Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay" and "Collagen-related peptides and uses thereof." The first patent provides methods that facilitate the identification of substrates of a protease, particularly focusing on ubiquitin and proteasome proteins. The second patent relates to a collagen-related polypeptide that can self-assemble into collagen mimetic structures, which has potential applications in tissue engineering and regenerative medicine.
Career Highlights
Throughout her career, Cejas has worked with companies such as Advanced Technologies and Regenerative Medicine, LLC and Lifesensors, Inc. Her innovative work has positioned her as a key figure in the development of new biotechnological solutions.
Collaborations
Cejas has collaborated with notable professionals in her field, including William Alvin Kinney and Bruce E. Maryanoff. These collaborations have further enhanced her research and development efforts.
Conclusion
Mabel Alarnino Cejas is a pioneering inventor whose work in synthetic protease substrates and collagen-related peptides has made a significant impact in biochemistry. Her contributions continue to influence advancements in medical and scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile